Novelix Pharmaceuticals Limited (BOM:536565)

Market Cap	2.30B +293.0%
Revenue (ttm)	1.47B +180.4%
Net Income	36.29M +565.3%
EPS	1.50 +198.8%
Shares Out	28.47M
PE Ratio	53.89
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,173
Open	83.99
Previous Close	80.38
Day's Range	78.00 - 83.99
52-Week Range	38.00 - 92.00
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Novelix Pharmaceuticals

Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1994
• Employees: 8
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 536565

Financial Performance

In fiscal year 2026, Novelix Pharmaceuticals's revenue was 1.32 billion, an increase of 330.60% compared to the previous year's 307.33 million. Earnings were 25.57 million, an increase of 2924.85%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 25, 2026

Data Sources Report a data error